Viruses are hot in the cancer community these days. Recent published reports have found that measles viruses and a cousin of rabies work to kill cancer. Now yet another one may revolutionize cancer therapy.

Days after receiving U.S. Food and Drug Administration (FDA) approval, the Abbott ALK test for non-small-cell lung cancer (NSCLC) has become available in the United States, European Union and New Zealand.

People living in poor countries have minimal access to basic healthcare, and sophisticated cancer tests are non-existent. Researchers are developing a device that could change that.

The younger a smoker is that decides to quit, obviously the better for their health. Women in their golden years can receive immediate benefits from quitting.

The battle against the power of cancer is being waged largely on the genetic front these days. Scientists have discovered another gene that could be targeted to treat two forms of the disease.

A virus that's in the rabies family holds promise in fighting a rare but lethal form of cancer found in children and young adults. Yale University researchers are working with this virus as a potential treatment.

The 9/11 nightmare lives on in the bodies - as well as the minds - of firefighters who were on the scene that fateful day. New research shows these heroes live with increased risks of cancer.

Patients with advanced liver cancer typically have few therapeutic options. Scientists have discovered that an existing technology offers new hope and days for these patients.

Killing healthy cells and tissue is one of the downsides of traditional cancer therapies. A team of scientists is in the process of "painting a bullseye on cancer cells" to remedy this problem.

Having cancer and undergoing chemotherapy as a young woman is traumatic enough. Researchers are now learning that chemotherapy can have a major impact on a woman's reproductive health - even years later.